Elena Helman

10.1k total citations · 1 hit paper
30 papers, 1.7k citations indexed

About

Elena Helman is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Elena Helman has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cancer Research, 14 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Elena Helman's work include Cancer Genomics and Diagnostics (20 papers), Molecular Biology Techniques and Applications (7 papers) and Lung Cancer Treatments and Mutations (5 papers). Elena Helman is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), Molecular Biology Techniques and Applications (7 papers) and Lung Cancer Treatments and Mutations (5 papers). Elena Helman collaborates with scholars based in United States, Switzerland and Argentina. Elena Helman's co-authors include Matthew Meyerson, Gad Getz, Eric S. Lander, Rameen Beroukhim, David Pellman, Douglas A. Levine, Peter W. Laird, Hui Shen, Wendy Winckler and Robert C. Onofrio and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and Bioinformatics.

In The Last Decade

Elena Helman

26 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Absolute quantification of somatic DNA alterations in human cancer

2012 1.1k citations Scott L. Carter, Kristian Cibulskis et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Elena Helman

Since Specialization

Citations

This map shows the geographic impact of Elena Helman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Helman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Helman more than expected).

Fields of papers citing papers by Elena Helman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Helman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Helman. The network helps show where Elena Helman may publish in the future.

Co-authorship network of co-authors of Elena Helman

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Helman. A scholar is included among the top collaborators of Elena Helman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Helman. Elena Helman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identifying Sarcocystis spp. infection in goats: a combined morphological, serological, and molecular approach 2025 ·Parasitology Research ·(unknown), (unknown), Elena Helman, Juan Manuel Unzaga, (unknown), Gastón Moré	0
2	Abstract 3119: A novel tissue resident memory T cell (TRM) signature predicts prognosis and tumor microenvironment of patients with melanoma 2023 ·Cancer Research ·Chongming Jiang, Jiànróng Lǐ, Elena Helman, Xiling Shen, Chao Cheng	0
3	Abstract 537: NTRK1 fusion detection from clinical cfDNA NGS using a de novo fusion caller 2021 ·Cancer Research ·Arielle Yablonovitch, Sante Gnerre, Jennifer Yen, Scott A. Shell, Elena Helman, Stephen R. Fairclough, Rebecca J. Nagy, Justin I. Odegaard, Darya Chudova, AmirAli Talasaz	3
4	Abstract 401: Comparison of molecular response calculations for prediction of patient outcome 2021 ·Cancer Research ·Allysia J. Mak, Katie Quinn, Carin R. Espenschied, Kyle Chang, Han‐Yu Chuang, Elena Helman, Darya Chudova, Justin I. Odegaard, (unknown), AmirAli Talasaz	1
5	A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study 2020 ·Clinical Cancer Research ·Han Si, Michael Kuziora, Katie Quinn, Elena Helman, Jiabu Ye, Feng Liu, Urban Scheuring, Solange Peters, Naiyer A. Rizvi, Philip Z. Brohawn, Koustubh Ranade, Brandon W. Higgs, Kimberly C. Banks, Vikram K. Chand, Rajiv Raja	86
6	Abstract 2509: Analysis of clonal hematopoiesis-associated mutations in the cell-free DNA of advanced cancer patients 2019 ·Jennifer Yen, Katie Quinn, Elena Helman, (unknown), Tracy Nance, Ariel Jaimovich, Kimberly C. Banks, Aleksandra Franovic, (unknown), John Latham, Arielle Yablonovitch, Marcin Sikora, Stephen R. Fairclough, Darya Chudova, Richard B. Lanman, AmirAli Talasaz	3
7	Abstract 1675: Analytical validation of MSI High detection with GuardantOMNI 2019 ·Cancer Research ·Jing Zhao, Alexander Artyomenko, Carlo G. Artieri, John Latham, Stephen R. Fairclough, Cátálin Bárbácioru, Elena Helman, John H. Strickler, Darya Chudova, Richard B. Lanman, AmirAli Talasaz	1
8	Abstract 2509: Analysis of clonal hematopoiesis-associated mutations in the cell-free DNA of advanced cancer patients 2019 ·Cancer Research ·Jennifer Yen, Katie Quinn, Elena Helman, (unknown), Tracy Nance, Ariel Jaimovich, Kimberly C. Banks, Aleksandra Franovic, (unknown), John Latham, Arielle Yablonovitch, Marcin Sikora, Stephen R. Fairclough, Darya Chudova, Richard B. Lanman, AmirAli Talasaz	1
9	Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor 2018 ·Clinical Lung Cancer ·Elena Helman, Minh Nguyen, Chris Karlovich, Darrin Despain, (unknown), Alexander I. Spira, Helena A. Yu, D. Ross Camidge, Thomas C. Harding, Richard B. Lanman, Andrew D. Simmons	52
10	Abstract 5603: Analytical validation of a comprehensive 500-gene ctDNA panel designed for immuno-oncology and DNA damage research 2018 ·Cancer Research ·Elena Helman, Carlo G. Artieri, James V. Vowles, Jennifer Yen, Tracy Nance, Marcin Sikora, (unknown), (unknown), Stefanie Mortimer, Darya Chudova, Justin I. Odegaard, Richard B. Lanman, AmirAli Talasaz	15
11	Somatic mutations in BRCA2, NFE2L2, ARID1A and NOTCH1 sensitize to anti-PDL1 therapy in multiple tumor types 2018 ·Annals of Oncology ·(unknown), Han Si, Brandon W. Higgs, Philip Z. Brohawn, Katie Streicher, Maria Jure‐Kunkel, Remya Raja, Elena Helman, Aleksandra Franovic, (unknown), Yashaswi Shrestha, (unknown), (unknown), Ikbel Achour, Jiabu Ye, P. Mukhopadhyay, (unknown), Giovanni Melillo, Shaad E. Abdullah, K. Ranade	4
12	Microsatellite instability detection by targeted sequencing of cell-free DNA 2018 ·Annals of Oncology ·(unknown), Marcin Sikora, Martina I. Lefterova, Victoria M. Raymond, (unknown), Cátálin Bárbácioru, (unknown), Elena Helman, Darya Chudova, Richard B. Lanman, Justin I. Odegaard, Jason Willis, Marwan Fakih, Scott Kopetz, AmirAli Talasaz	5
13	Abstract P3-03-04: Establishment and characterization of ESR1-mutant breast cancer PDX models 2016 ·Cancer Research ·(unknown), Elena Helman, (unknown), (unknown), (unknown), A. W. Tolcher, Drew Rasco, Amita Patnaik, (unknown), M. Beeram, (unknown)	1
14	Analytical validation of comprehensive assays for genomic profiling of cancer from DNA and RNA 2016 ·European Journal of Cancer ·Julia Beck, Erin Newburn, Matthew D. Clark, Martina I. Lefterova, Elena Helman, Ravi Alla, Deanna M. Church, (unknown), Shiyu Luo, (unknown), Jason Harris, Nan Leng, Christian Haudenschild, (unknown), Jeffrey West	0
15	Abstract 1457: Genomic characterization of a PDX model of T-DM1-resistant HER2+ invasive ductal carcinoma using augmented exome sequencing 2015 ·Cancer Research ·Elena Helman, Michael J. Wick, Michael Clark, (unknown), Seán Boyle, Kyriakos P. Papadopoulos, Shujun Luo, Anthony W. Tolcher, Parin Sripakdeevong, Mirian Karbelashvili, Deanna M. Church, Richard Chen, John West	4
16	Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing 2014 ·Genome Research ·Elena Helman, Michael S. Lawrence, Chip Stewart, Carrie Sougnez, Gad Getz, Matthew Meyerson	161
17	Mutational heterogeneity in cancer and the search for new cancer genes 2013 ·DSpace@MIT (Massachusetts Institute of Technology) ·Elena Helman, Eric S. Lander	9
18	Association of halothane sensitivity with growth and meat quality in pigs 2012 ·animal ·R. O. Bates, M. E. Doumit, Nancy E. Raney, Elena Helman, Catherine W. Ernst	7
19	Absolute quantification of somatic DNA alterations in human cancer breakdown → 2012 ·Nature Biotechnology ·Scott L. Carter, Kristian Cibulskis, Elena Helman, Aaron McKenna, Hui Shen, Travis Zack, Peter W. Laird, Robert C. Onofrio, Wendy Winckler, Barbara A. Weir, Rameen Beroukhim, David Pellman, Douglas A. Levine, Eric S. Lander, Matthew Meyerson, Gad Getz	1148
20	DNA hypermethylation in lung cancer is targeted at differentiation-associated genes 2011 ·Oncogene ·Elena Helman, Kamila Naxerova, Isaac S. Kohane	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact